Enhancement of Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus
Cholera toxin (CT) is the most potent known mucosal adjuvant, but its toxicity precludes its use in humans. Here, in an attempt to develop safe and effective mucosal adjuvants, we compared immune responses to simian immunodeficiency virus (SIV) virus-like particles (VLPs) after intranasal coimmuniza...
שמור ב:
| הוצא לאור ב: | J Virol |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
2003
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149534/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12610137/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.6.3615-3623.2003 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|